Literature DB >> 17004089

Prevalence and localization of nodal metastases in squamous cell carcinoma of the oral cavity: role and extension of neck dissection.

Luca Oscar Redaelli De Zinis1, Andrea Bolzoni, Cesare Piazza, Piero Nicolai.   

Abstract

Lymph node (LN) metastases represent the most important negative prognostic factor in squamous cell carcinoma (SCC) of the oral cavity, even though controversies still exist regarding their management. The aim of this study was to retrospectively analyze our experience in surgical management of SCC of the oral cavity with particular focus on the prevalence and localization of lymph nodal metastases and recurrences. The clinical records of 89 consecutive patients treated from 1983 to 2002 by concomitant surgery on both the T and N sites, excluding those undergoing salvage surgery, were reviewed. A total of 119 neck dissections (ND) were performed. Survival outcomes were calculated by the Kaplan-Meier method, while univariate comparisons by the log-rank and non-parametric tests were performed between different groups of patients. Five-year overall and determinate survivals were 50 and 57%, respectively. LN metastases were observed in 52% (56% of these showing extracapsular spread) and their presence strongly correlated with determinate survival (p < 0.0001). The prevalence of clinical and occult nodal disease was not related to the pT status. Neck levels II (59%) and I (56%) were most frequently involved. Metastases to level IV accounted for 15% of positive LN, even though 28% of them turned out to be skip metastases. Five neck recurrences were observed, only one of which was salvaged by surgery. The high prevalence of clinical and occult LN metastases in this setting suggests that ND should be performed on a nearly routine basis, even for lesions with a low-T category and a cN0 neck. Moreover, ND should always encompass level IV due to the possibility of skip metastases, particularly in tumors involving the oral tongue. In patients with a cN+ neck, levels from I to V should be addressed, particularly in the presence of metastases at levels III and IV.

Entities:  

Mesh:

Year:  2006        PMID: 17004089     DOI: 10.1007/s00405-006-0128-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  23 in total

1.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery.

Authors:  K Thomas Robbins; Garry Clayman; Paul A Levine; Jesus Medina; Roy Sessions; Ashok Shaha; Peter Som; Gregory T Wolf
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-07

Review 2.  Nodal metastases: predictive factors.

Authors:  L P Kowalski; J E Medina
Journal:  Otolaryngol Clin North Am       Date:  1998-08       Impact factor: 3.346

3.  The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections.

Authors:  M W van den Brekel; I van der Waal; C J Meijer; J L Freeman; J A Castelijns; G B Snow
Journal:  Laryngoscope       Date:  1996-08       Impact factor: 3.325

4.  Effectiveness of selective neck dissection for management of the clinically negative neck.

Authors:  K T Pitman; J T Johnson; E N Myers
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1997-09

5.  Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival.

Authors:  Wynia Derks; Rob J de Leeuw; Gerrit Jan Hordijk
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2005-04       Impact factor: 2.064

6.  Management of the neck in N0 squamous cell carcinoma of the oral cavity.

Authors:  D Kramer; J S Durham; S Jackson; J Brookes
Journal:  J Otolaryngol       Date:  2001-10

7.  Prognostic indicators of occult metastases in oral cancer.

Authors:  Mario Russolo; Vittorio Giacomarra; Ledia Papanikolla; Giancarlo Tirelli
Journal:  Laryngoscope       Date:  2002-03       Impact factor: 3.325

8.  Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer.

Authors:  Misa Sumi; Noriyuki Sakihama; Tadateru Sumi; Minoru Morikawa; Masataka Uetani; Hiroyuki Kabasawa; Koichiro Shigeno; Kuniaki Hayashi; Haruo Takahashi; Takashi Nakamura
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

9.  Computed tomographic evaluation of regional lymph node involvement in cancer of the oral cavity and oropharynx.

Authors:  L G Close; M Merkel; M F Vuitch; J Reisch; S D Schaefer
Journal:  Head Neck       Date:  1989 Jul-Aug       Impact factor: 3.147

10.  Reduction of occult metastatic disease by extension of the supraomohyoid neck dissection to include level IV.

Authors:  St-John Crean; A Hoffman; John Potts; M J Fardy
Journal:  Head Neck       Date:  2003-09       Impact factor: 3.147

View more
  16 in total

1.  Predictors of extracapsular spread in lymph node metastasis.

Authors:  Kadir Imre; Ercan Pinar; Semih Oncel; Caglar Calli; Bekir Tatar
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-09-27       Impact factor: 2.503

2.  Assessment of the Rate of Skip Metastasis to Neck Level IV in Patients With Clinically Node-Negative Neck Oral Cavity Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.

Authors:  Anton Warshavsky; Roni Rosen; Narin Nard-Carmel; Sara Abu-Ghanem; Yael Oestreicher-Kedem; Avraham Abergel; Dan M Fliss; Gilad Horowitz
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-06-01       Impact factor: 6.223

3.  Level IIb Neck Dissection in Oral Cavity Cancers- When Should One Address it..?

Authors:  Jyoti Pralhad Dabholkar; Neeti Madan Kapre
Journal:  Indian J Surg Oncol       Date:  2015-09-16

4.  Management of the node negative early carcinoma tongue.

Authors:  Ajith Nilakantan; M D Venkatesh; Dilip Raghavan; Rakesh Datta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2007-10-05

5.  Patients with unilateral squamous cell carcinoma of the tongue and ipsilateral lymph node metastasis do not profit from bilateral neck dissection.

Authors:  Christoph Klingelhöffer; Andreas Gründlinger; Gerrit Spanier; Stephan Schreml; Maximilian Gottsauner; Steffen Mueller; Johannes K Meier; Torsten E Reichert; Tobias Ettl
Journal:  Oral Maxillofac Surg       Date:  2018-03-29

Review 6.  Current philosophy in the surgical management of neck metastases for head and neck squamous cell carcinoma.

Authors:  H Hakan Coskun; Jesus E Medina; K Thomas Robbins; Carl E Silver; Primož Strojan; Afshin Teymoortash; Phillip K Pellitteri; Juan P Rodrigo; Sandro J Stoeckli; Ashok R Shaha; Carlos Suárez; Dana M Hartl; Remco de Bree; Robert P Takes; Marc Hamoir; Karen T Pitman; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2014-06-30       Impact factor: 3.147

7.  Discontinuous vs. in-continuity neck dissection in carcinoma of the oral cavity. Experience of two oncologic hospitals.

Authors:  M A S Tesseroli; L Calabrese; A L Carvalho; L P Kowalski; F Chiesa
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-12       Impact factor: 2.124

Review 8.  The role of neck dissection in squamous cell carcinoma of the head and neck.

Authors:  Marc Hamoir; Sandra Schmitz; Vincent Gregoire
Journal:  Curr Treat Options Oncol       Date:  2014-12

9.  Prediction of lymph node metastasis in oral tongue squamous cell carcinoma using the neutrophil-to-lymphocyte ratio and platelet-to-neutrophil ratio.

Authors:  Bo Wang; Junwen Liu; Zhengrong Zhong
Journal:  J Clin Lab Anal       Date:  2021-05-04       Impact factor: 2.352

10.  Detecting cancer metastasis and accompanying protein biomarkers at single cell levels using a 3D-printed microfluidic immunoarray.

Authors:  Mohamed Sharafeldin; Tianqi Chen; Gulsum Ucak Ozkaya; Dharamainder Choudhary; Alfredo A Molinolo; J Silvio Gutkind; James F Rusling
Journal:  Biosens Bioelectron       Date:  2020-10-15       Impact factor: 10.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.